Kang Zhang

Kang Zhang () is a Chinese-American ophthalmologist specializing in ophthalmic genetics and aging processes in the eye. He is currently a professor of the Faculty of Medicine at Macau University of Science and Technology. He was previously a professor of ophthalmology and the founding director of the Institute for Genomic Medicine at the University of California, San Diego, but after being involved in controversies including unethnical behavior and "objectional conditions" at UCSD, which prompted an FDA probe that barred Zhang from "overseeing human research studies" in 2017, as well as undisclosed and questionable ties to Chinese companies Zhang moved to China. Zhang is particularly known for his controversies and for his work on lanosterol, stem cell research (particularly limbal stem cells), gene editing, and artificial intelligence. Provided by Wikipedia